Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Skin and hair aging involves mitochondrial issues, telomere shortening, and hormonal changes, with iron affecting hair loss in pre-menopausal women.

Age, sex, BMI, menopause, and specific genes affect hair density in East Asians.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Early postmenopausal women often experience skin issues like vaginal dryness, swallowing difficulties, hair loss, and uncommonly, keratoderma and hirsutism, but many are unaware these are related to menopause.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Including androgens in hormone therapy may lower breast cancer risk.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

The April 2014 issue of "Fertility and Sterility" discussed various reproductive health topics, including hormone therapy benefits, sperm and genetic factors in male infertility, and the link between PCOS and diabetes.

PCOS management includes lifestyle changes and medications, with ongoing research into repurposed drugs for better treatment options.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

Chemotherapy can harm kidneys in breast cancer patients.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Blackcurrant extract may help reduce hair loss by promoting stem cell activity in hair follicles.

The patient's high testosterone was reduced by a medication that suppresses gonadotropin.

The document concludes that more research is needed to understand how PRP affects the ovaries and to standardize its use in treatment.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Lugol's solution can cause thyroid problems if used long-term for non-approved reasons.

Low iron levels are not linked to hair loss in women with androgenetic alopecia.

Increasing sleep by 41 minutes daily for a month showed no significant changes in metabolism or hormone levels in healthy women.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

An ovarian tumor caused a woman's male-like symptoms, which improved after surgery.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Androgens and DHEA can help prevent breast cancer and improve health in women.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Men over 50 may experience hormone decline causing various symptoms, and proper management is crucial.

Women with PCOS have higher androgen levels that decrease with age but are still higher than in women without PCOS.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.